Drug Type T-lymphocyte cell therapy |
Synonyms Antiinfluenza A Tcell therapy Tevogen Bio |
Target- |
Mechanism Immunologic cytotoxicity, T lymphocyte replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Tevogen Bio Inc.Startup |
Active Organization Tevogen Bio Inc.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Influenza A virus infection | Preclinical | US | Tevogen Bio Inc.Startup | - |